8-K: Taitron Delists from Nasdaq, Reports Q3 Loss

Taitron Components Incorporated announced its voluntary delisting from Nasdaq, deregistration, and reported a net loss for the third quarter and first nine months of 2025.

Summary

• The Board of Directors approved the voluntary delisting of common stock from The Nasdaq Stock Market and deregistration under the Securities Exchange Act of 1934, suspending public reporting obligations.
• The decision was based on the conclusion that compliance costs, management time, and company resources required for public listing and reporting outweigh the benefits.
• David Vanderhorst resigned as Chief Financial Officer and Secretary, effective November 10, 2025, but will remain as the Company's Controller.
• Stewart Wang, President and Chief Executive Officer, has assumed the duties of principal financial officer and principal accounting officer.
• For the three months ended September 30, 2025, net product revenue decreased to $529,000 from $1,187,000 in the prior year period.
• The company reported a net loss of $(58,000) for Q3 2025, compared to a net income of $245,000 for Q3 2024.
• Basic net loss per share for Q3 2025 was $(0.01), down from basic net income per share of $0.04 in Q3 2024.
• For the nine months ended September 30, 2025, net product revenue was $2,778,000, down from $3,374,000 in the prior year period.
• A significant restructuring and severance expense of $1,680,000 was incurred for the nine months ended September 30, 2025.
• The company reported a net loss of $(671,000) for the first nine months of 2025, a substantial decline from a net income of $1,203,000 in the same period of 2024.
• Basic net loss per share for the nine months ended September 30, 2025, was $(0.11), compared to basic net income per share of $0.20 in the prior year period.
• Cash dividends declared per common share decreased to $0.035 for Q3 2025 from $0.050 for Q3 2024, and to $0.135 for the nine months ended September 30, 2025, from $0.150 for the same period in 2024.
• Total assets decreased to $17,085,000 as of September 30, 2025, from $17,636,000 as of December 31, 2024.
• Total current liabilities increased to $2,023,000 as of September 30, 2025, from $1,073,000 as of December 31, 2024, primarily due to an accrued restructuring reserve of $1,256,000.

Sentiment

Score: 2

Explanation: The sentiment is highly negative due to the voluntary delisting from Nasdaq, the significant decline in revenue and profitability, and the shift to a net loss. The reduction in transparency for investors post-deregistration further contributes to the negative outlook.

Negatives

• Voluntary delisting from Nasdaq, leading to reduced liquidity and visibility for shareholders.
• Deregistration and suspension of public reporting obligations, significantly reducing transparency for investors.
• Significant decline in net product revenue for both the three-month and nine-month periods ended September 30, 2025.
• Shift from net income to a net loss for both the third quarter (from $245,000 income to $(58,000) loss) and the first nine months of 2025 (from $1,203,000 income to $(671,000) loss).
• Incurrence of $1,680,000 in restructuring and severance expenses for the nine months ended September 30, 2025.
• Decrease in cash dividends declared per common share.
• Resignation of the Chief Financial Officer and Secretary, indicating a significant change in financial leadership.

Risks

• No assurance that trading in common stock will continue on the OTC Markets Group or otherwise after Nasdaq delisting.
• Termination of public reporting obligations will result in significantly less information available to investors, potentially impacting valuation and liquidity.
• The company's actual results could differ materially from forward-looking statements due to various factors, as mentioned in SEC filings.

Future Outlook

The company expects its Nasdaq delisting to become effective on or about December 4, 2025, after which trading on Nasdaq will cease. Common stock may be eligible for quotation on the Pink tier of OTC Markets Group, but no assurance is provided. Following the filing of Form 15 on or about December 8, 2025, the company anticipates suspending its periodic reporting obligations under the Exchange Act, with all associated requirements terminating permanently 90 days thereafter.

Management Comments

• Our Board of Directors concluded that the costs of maintaining the Nasdaq listing and remaining a public reporting company, including costs of compliance, the demands on management time and the Company resources required to maintain its listed and registered status, outweigh the benefits to the Company and its stockholders of continued Nasdaq listing and SEC reporting.
• The Company can provide no assurance that trading in its common stock will continue on the OTC Markets Group or otherwise.

Industry Context

The filing does not provide specific industry context or trends, focusing solely on company-specific operational and financial decisions. The decision to delist and deregister suggests a move away from the public market, potentially due to the burdens of public company compliance relative to the company's size or market capitalization, which can be a trend for smaller public entities facing high regulatory costs.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Will lose the liquidity and visibility associated with a Nasdaq listing, and will experience reduced transparency due to the cessation of SEC periodic reporting. Trading may become less accessible and less liquid on OTC Markets Group, if at all.
• Management: Will experience reduced compliance burdens and demands on time previously dedicated to public company reporting requirements.
• Employees: David Vanderhorst remains an employee as Controller, indicating a restructuring of roles rather than a full departure from the company.

Next Steps

• File Form 25 with the SEC on or about November 24, 2025.
• Nasdaq delisting to become effective on or about December 4, 2025, ceasing trading on Nasdaq.
• File Form 15 with the SEC on or about December 8, 2025, to suspend periodic reporting obligations.
• Potential eligibility for quotation on the Pink tier of OTC Markets Group, though no assurance is provided.
• Termination of all Exchange Act-registered company requirements 90 days after Form 15 filing.

Key Dates

Recommendation

The company's decision to voluntarily delist from Nasdaq and deregister, coupled with a significant decline in revenue and a shift to net losses for both the quarter and year-to-date, signals a highly negative outlook for public shareholders. The loss of a major exchange listing will severely impact liquidity and market visibility, while the cessation of SEC reporting will drastically reduce transparency. These factors, combined with deteriorating financial performance, make the stock a strong sell for investors seeking liquidity and transparent financial reporting.

Keywords

Taitron Components, TAIT, Nasdaq delisting, deregistration, Q3 2025 earnings, financial results, CFO resignation, Stewart Wang, David Vanderhorst, electronic components, public reporting, OTC Markets